Cargando…
Immunohistochemical and molecular detection of the expression of FGF23 in phosphaturic mesenchymal tumors including the non-phosphaturic variant
BACKGROUND: Phosphaturic mesenchymal tumors (PMTs) are rare neoplasms that are often associated with tumor-induced osteomalacia (TIO) due to excessive serum levels of fibroblast growth factor 23 (FGF23). PMTs share overlapping histologic features with other types of tumors; thus, accurate pathologic...
Autores principales: | Shiba, Eisuke, Matsuyama, Atsuji, Shibuya, Ryo, Yabuki, Kei, Harada, Hiroshi, Nakamoto, Mitsuhiro, Kasai, Takahiko, Hisaoka, Masanori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4784377/ https://www.ncbi.nlm.nih.gov/pubmed/26956379 http://dx.doi.org/10.1186/s13000-016-0477-3 |
Ejemplares similares
-
Utility of Multimodality Approach Including Systemic FGF23 Venous Sampling in Localizing Phosphaturic Mesenchymal Tumors
por: Kato, Hajime, et al.
Publicado: (2022) -
Clinical, histopathologic, subtype, and immunohistochemical analysis of jaw phosphaturic mesenchymal tumors
por: Li, Dongmei, et al.
Publicado: (2020) -
Phosphaturic mesenchymal tumor: Case report
por: Richardson, Adam L., et al.
Publicado: (2019) -
Phosphaturic mesenchymal tumor and related wound problem
por: Xiao, Xian, et al.
Publicado: (2018) -
Clinical and imaging features of phosphaturic mesenchymal tumors
por: Chang, Cheng, et al.
Publicado: (2023)